All In Biotech

Free tool

FAERS Monitor: Eylea Hd

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761355 or its brand name (Eylea Hd, Aflibercept). Reports on generic versions are filed under their own applications.

Reports

4,671

Serious

4,088

88% of reports

Hospitalization

1,536

Death reported

439

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use506
  • diarrhoea380
  • visual acuity reduced221
  • neutropenia215
  • hypertension210
  • endophthalmitis207
  • visual impairment179
  • vision blurred169
  • asthenia155
  • disease progression154
  • drug ineffective153
  • eye inflammation150
  • eye pain132
  • vitritis125
  • nausea124

Reports by year received

View as table
YearReports
20075
20082
200911
201045
201127
201257
2013240
2014162
2015159
2016180
2017182
2018532
2019328
2020212
2021200
2022170
2023222
2024505
2025789
2026643

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,488 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
vitritisSignal125326.0272.537,467
endophthalmitisSignal207160.9140.531,612
eye inflammationSignal15071.961.310,258
visual acuity reducedSignal22130.226.56,170
eye painSignal13210.68.91,133
neutropeniaSignal2157.16.31,132
visual impairmentSignal1796.55.6833
disease progressionSignal1545.95.0620
vision blurredSignal1695.54.8629
hypertensionSignal2104.53.9567
diarrhoeaSignal3802.72.4401
off label useSignal5062.62.4519
asthenia1551.91.661
nausea1240.70.616
drug ineffective1530.50.471

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.